fda stance on compounded semaglutide The announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company Hims & Hers to yank its new (Wegovy) weight-loss pill from the How FDA Crackdowns Are Affecting

10.3390/microorganisms13061211 43 KodaY.TerataniT.ChuP.-S.HagiharaY.MikamiY.HaradaY.et al (2021)

This is much more robust weight loss than Wevogy or Zepbound, says Jody Dushay, MD, an assistant professor at Harvard Medical School and an endocrinologist at Beth Israel Deaconess Medical Center in Boston, who was not involved in the study

In the SURMOUNT-1 clinical trial, patients taking the highest dose of Mounjaro (15mg) lost an average of 22.5% of their body weight over 72 weeks

But what if there was a tool that could work with your body to help you achieve your goals

You know, you take a drug like ozempic, its extremely expensive

You can also request a discreet screening if needed